| Mon, Nov 9, 2009 | | • | Healthcare Bill Will Be Law By New Year Says Morningstar Strategist
Wall Street Transcript (Mon 1:53pm)
| | Thu, Nov 5, 2009 | | • | AMYLIN PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 5)
| | • | Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
PR Newswire (Thu, Nov 5)
| | • | Amylin To Live Large On The Fat Of The Land
at Forbes.com (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Roll up for Japan's medical mystery tour
at FT.com (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | Amylin Scores a Hat Trick
at Motley Fool (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | Bulls Target Bebe, Crocs: Options Recap
at TheStreet.com (Mon, Nov 2)
| | • | Takeda / Amylin
at FT.com (Mon, Nov 2)
| | • | UPDATE - US FDA issues alert on kidney problems with Byetta
at Reuters (Mon, Nov 2)
| | • | [$$] Stocks in the Spotlight Monday
at Barrons.com (Mon, Nov 2)
| | • | Amylin signs weight-loss drug deal with Takeda
AP (Mon, Nov 2)
| | • | FDA adds kidney health warnings to Byetta label
AP (Mon, Nov 2)
| | • | Innovative Drug Companies Headline the Gainers
at Seeking Alpha (Mon, Nov 2)
| | • | AMYLIN PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Nov 2)
| | • | Amylin Pharma: Calls Ride the Rally
at Seeking Alpha (Mon, Nov 2)
| | • | Don't Expect Amylin to Eat the Obesity Market's Lunch
at Seeking Alpha (Mon, Nov 2)
| | • | Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Update
PR Newswire (Mon, Nov 2)
| | • | Biopharma's Bustin' Out All Over
at CNBC (Mon, Nov 2)
| | • | Amylin Strikes First With Obesity Drug Deal
at TheStreet.com (Mon, Nov 2)
| | • | Amylin Makes Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
|
Add AMLN News to My Yahoo!:
 
| |
|
2.03% Nasdaq 0.00%
Headlines
